The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders
ChemMedChem - United Kingdom
doi 10.1002/cmdc.201900176
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 21, 2019
Authors
Publisher
Wiley